143 related articles for article (PubMed ID: 4554823)
1. Pharmacological study of a new hypoglycaemic sulphonamide: glisoxepid (RP 22410).
Loubatières A; Mariani MM; Ribes G; Alric R; Agot H
Diabetologia; 1972 Feb; 8(1):29-36. PubMed ID: 4554823
[No Abstract] [Full Text] [Related]
2. [Pharmacological comparison between tolbutamide and two second generation hypoglycemic sulfonylureas (glibenclamide and glisoxepide)].
Loubatières A; Ribes G; Mariani MM; Alric R
Acta Diabetol Lat; 1973; 10(2):261-82. PubMed ID: 4200420
[No Abstract] [Full Text] [Related]
3. [Effect of glycemia level on insulin secretion caused by an hypoglycemic sulfamide (glisoxepide) in dogs].
Loubatières AL; Ribes G; Loubatières-Mariani MM
C R Seances Soc Biol Fil; 1972; 166(8):1047-50. PubMed ID: 4573746
[No Abstract] [Full Text] [Related]
4. Dynamics of sulfonylurea-induced insulin release from the isolated perfused rat pancreas.
Gotfredsen CF
Diabetologia; 1976 Aug; 12(4):339-42. PubMed ID: 134920
[TBL] [Abstract][Full Text] [Related]
5. [Pharmacological studies of a new highly effective blood sugar decreasing sulfonamide, glibenclamide (HB 419)].
Loubatières A; Mariani MM; Ribes G; de Malbosc H; Alric R; Chapal J
Arzneimittelforschung; 1969 Aug; 19(8):Suppl:1354-63. PubMed ID: 4899083
[No Abstract] [Full Text] [Related]
6. [Insulin liberation by blood sugar decreasing sulfonamides and by glucose in adult diabetic patients].
Haupt E; Köberich W; Rosak C; Beyer J; Schöffling K
Arzneimittelforschung; 1972 Dec; 22():Suppl 12A:2198. PubMed ID: 4198967
[No Abstract] [Full Text] [Related]
7. The pharmacology of a new hypoglycaemic agent N-[4-(2-(2,3-dihydrobenzo(b)furan-m-carboxamido)-ethyl)-benzenesulphonyl]-N'-cyclohexylurea (NOVO CS 476). I. Pharmacological studies on the hypoglycaemic effect.
Jorgensen KD
Acta Pharmacol Toxicol (Copenh); 1977 Feb; 40(2):216-26. PubMed ID: 402791
[TBL] [Abstract][Full Text] [Related]
8. Analysis of the stimulating action of tolbutamide on the secretion of insulin using mannoheptulose and diazoxide.
Loubatières-Mariani MM; Loubatières AL; Chapal J
Diabetologia; 1973 Apr; 9(2):152-7. PubMed ID: 4716116
[No Abstract] [Full Text] [Related]
9. [Studies on new sulfonylurea derivatives and their metabolites in isolated Langerhans's islets of the rat pancreas (author's transl].
Krause U; Puchinger H; Wacker A
Arzneimittelforschung; 1975 Aug; 25(8):1231-3. PubMed ID: 810148
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological comparison between tolbutamide and two second generation hypoglycemic sulfonylureas (glibenclamide and glisoxepide).
Loubatiéres A; Mariani MM; Ribes G; Alric R
Acta Diabetol Lat; 1973; 10(2):261-82. PubMed ID: 4200675
[No Abstract] [Full Text] [Related]
11. [Insulin secretion as studied on isolated perfused rat pancreas. I. Synergism between glucose and hypoglycaemic sulphonamides].
Loubatières A; Mariani MM; Chapal J
Diabetologia; 1970 Oct; 6(5):457-66. PubMed ID: 4919967
[No Abstract] [Full Text] [Related]
12. [Experimental study of glipizide. A comparison with other hypoglycemic sulfonamides (author's transl)].
Loubatières AL; Loubatieres-Mariani MM; Alric R; Ribes G; Sorial G; Tarasco A
Diabete Metab; 1975 Mar; 1():13-21. PubMed ID: 824163
[TBL] [Abstract][Full Text] [Related]
13. [Pharmacologic study with glisoxepide and other blood sugar reducing sulfonamide derivatives in metabolically healthy subjects and diabetics].
Haupt E; Beyer J; Schöffling K
Arzneimittelforschung; 1974 Mar; 24(0):418-25. PubMed ID: 4211557
[No Abstract] [Full Text] [Related]
14. Effects of feeding and fasting on the insulin secretory response to glucose and sulfonylureas in intact rats and isolated perfused rat pancreas.
Bosboom RS; Zweens J; Bouman PR
Diabetologia; 1973 Aug; 9(4):243-50. PubMed ID: 4203349
[No Abstract] [Full Text] [Related]
15. The pharmacology of S 1702, a new highly effective oral antibiabetic drug with unusual properties. 1. Pharmacological and hypoglycaemic activity, studies in different animal species.
Duhault J; Boulanger M; Tisserand F; Bergi L
Arzneimittelforschung; 1972 Oct; 22(10):1682-5. PubMed ID: 4677056
[No Abstract] [Full Text] [Related]
16. Effects of tolbutamide on insulin and glucagon secretion of the isolated perfused rat pancreas.
Laube H; Fussgänger R; Goberna R; Schröder K; Straub K; Sussman K; Pfeiffer EF
Horm Metab Res; 1971 Jul; 3(4):238-42. PubMed ID: 4256979
[No Abstract] [Full Text] [Related]
17. [Current concepts of the pancreatic and extrapancreatic mechanisms of the action of peroral hypoglycemic sulfonylurea preparations].
Poltorak VV; Gladkikh AI
Probl Endokrinol (Mosk); 1985; 31(2):76-85. PubMed ID: 2859589
[No Abstract] [Full Text] [Related]
18. Phosphoinositide hydrolysis and insulin secretion in response to glucose stimulation are impaired in isolated rat islets by prolonged exposure to the sulfonylurea tolbutamide.
Zawalich WS
Endocrinology; 1989 Jul; 125(1):281-6. PubMed ID: 2544404
[TBL] [Abstract][Full Text] [Related]
19. [Secretion of insulin under the influence of sulfonylurea derivates (SH)].
Rothenbuchner G; Raptis S; Pfeiffer EF
Wien Z Inn Med; 1973; 54(2):69-77. PubMed ID: 4203274
[No Abstract] [Full Text] [Related]
20. Glypentide: a new hypoglycaemic agent.
Morell J
Biochem Pharmacol; 1974 Oct; 23(20):2922-4. PubMed ID: 4429592
[No Abstract] [Full Text] [Related]
[Next] [New Search]
